Literature DB >> 27828656

Profile of patients receiving medical care at a reference, support, and treatment center for psoriasis patients at a university hospital.

Túlio Germano Machado Cordeiro1, Bruno D' Paula Andrade1, Esther Bastos Palitot1, Márcia Regina Piuvezam1, Sandra Rodrigues Mascarenhas1.   

Abstract

Psoriasis is a chronic, inflammatory, immune-mediated disease affecting 1-3% of the population worldwide. This work seeks to draw a profile of patients with psoriasis, analyzing socioeconomic, anthropometric, and clinical aspects. For this, medical records from 81 individuals who received medical care in a university hospital in 2014 were consulted. It was observed that the patients were mostly dark-skinned black adult men, with a low education level and a low income, who were sedentary, former smokers, obese, with an increase in waist circumference, and who did not consume alcohol. Psoriasis vulgaris predominated, beginning mainly on the scalp, hands, and feet. In addition, many presented some type of associated comorbidity and had relatives with psoriasis.

Entities:  

Mesh:

Year:  2016        PMID: 27828656      PMCID: PMC5087241          DOI: 10.1590/abd1806-4841.201644945

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


Psoriasis is a chronic, inflammatory, erythematous scaly, immune-mediated disease, which occurs universally, affecting men and women equally in 1-3% of the population worldwide.[1,2] The physiopathology involves immune system, genetic and environmental components.[1,2] It is characterized by the expansion and activation of Th1, Th17, Th22, and T-cells, with the production of the associated cytokines, such as Interferon, the tumor necrosis factor (TNF), interleukin 17 (IL17), and IL22 on the skin.[3,4] Factors such as traumas, acute and intense exposure to sunlight, infections, certain drugs, psychogenic and emotional factors, smoking, alcohol, and endocrine factors may trigger or worsen psoriatic lesions. For this prospective and observational study, 81 patients treated at a psoriasis reference center in a university hospital were selected. The project was approved by the Human Research Ethics Committee. The following data were verified: gender, skin color, age group, education level, income level, per capita income, smoking, alcoholism, sedentary lifestyle, abdominal circumference, Body Mass Index (BMI), type of psoriasis, sites and age when the lesions began, presence of comorbidities, existence of relatives with psoriasis, and occurrence of psoriatic arthritis. The majority of people, 75 (92.6%), were 18 years of age or older. In addition, in 31 cases (38.6%), the first lesions appeared earlier than or at 18 years of age, affecting both genders equally (Table 1).
Table 1

Psoriasis patients' socioeconomic characteristics and habits (n=81). João Pessoa (PB), Brazil, 2014

VariableAbsolute frequency (n)Relative frequency (%)
Gender  
    Male4353.1
    Female3846.9
Skin color  
    White2733.3
    Dark-skinned4555.6
    Black911.1
Age group  
    Children (0-11 years of age)44.9
    Adolescents (12-18 years of age)22.5
    Adults (19-59 years of age)6175.3
    Senior citizens (> or = 60 years of age)1417.3
Education level  
    Illiterate1012.3
    Elementary school - incomplete2530.9
    Elementary school - complete1417.3
    High school - incomplete22.5
    High school - complete2125.9
    College degree - incomplete11.2
    College degree - complete89.9
Per capita income  
    Up to minimum wage6074.1
    1 to 3 times minimum wages1822.2
    Over 3 times minimum wages33.7
Smoking  
    Smokers1417.3
    Non-smokers4454.3
    Ex-smokers2328.4
Alcohol consumption  
    Consumes alcohol2227.2
    Does not consume alcohol4150.6
    No longer consumes alcohol1822.2
Exercising  
    Exercises2328.4%
    Does not exercise5871.6%
Total81100%
Psoriasis patients' socioeconomic characteristics and habits (n=81). João Pessoa (PB), Brazil, 2014 Data showed that 45 patients (55.6%) were dark-skinned, 27 (33.3%) were white, and 9 (11.1%) were black (Table 1). This result is in disagreement with the majority of the literature, in which occurrences in people with white skin have been more prevalent, as psoriasis tends to be rare in black, indigenous, and Asian people.[3,5] It was determined that, predominantly, 60 (74.1%) of the people were paid under the minimum wage, and 25 (30.9%) had not completed elementary school, thus reflecting the socioeconomic status of most of the Brazilian Unified Health System (SUS) users (Table 1). Studies show that smoking and alcohol consumption, in addition to being risk and worsening factors of the disease, also reduce patient response to treatment.[6,7] In this sense, the majority, 44 individuals (54.3%), consisted of ex-smokers, and 41 (50.6%) did not consume alcohol (Table 1). In this study, 58 patients (71.6%) stated that they do not exercise (Table 1). It is known that regular exercise, at moderate intensity, improves some risk factors (mental health, vitality, body composition, sleeping), in addition to helping insulin and psoriasis control.[8] It has been reported that psoriasis favors weight increase and obesity.[1,8,9] Studies show a relation between obesity and chronic inflammation, in which the fatty tissue is part of the immune system and the number of adipocytes is proportional to that of macrophages. An association can be observed between high levels of TNFα, IL6, IL17, leptin, and C-reactive protein, and increases in BMI, which contribute to alterations in insulin biochemical pathways, leading to insulin resistance, and contributes to the increase in lipid levels, triglycerides, type II diabetes, and cardiovascular diseases. The inflammatory state, in obese individuals, is also related to the development or worsening of psoriasis.[3,9] In this aspect, the research revealed that 26 people (32.1%) were overweight, 33 (40.7%) were obese, and 48 (59.3%) presented a high abdominal circumference (Table 2).
Table 2

Anthropometric measurements and clinical characteristics of psoriasis patients (n=81). João Pessoa (PB), Brazil, 2014

VariableAbsolute frequency (n)Relative frequency (%)
BMI (kg/m2)*  
    Low weight (< 18.5 kg/m244.9
    Normal weight (18.5-24.9 kg/m2)1822.2
    Pre-obese (25.0 -29.9 kg/m2)2632.1
    Grade I obesity (30.0 -34.9 kg/m2)1113.6
    Grade II obesity (35.0 -39.9 kg/m2)1822.2
    Grade III obesity (≥ 40 kg/m2)44.9
Abdominal circumference (cm) **  
Males  
    >90 cm1330.2
    <90 cm3069.3
Females  
    >80cm3592.1
    <80cm37.9
Comorbidities  
    Diabetes1822.2
    Dyslipidemias1417.3
    Hypertension2530.9
    Atopies (asthma, rhinitis, or atopic dermatitis)1012.3
    Cardiovascular diseases11.2
    Eye diseases44.9
    Absence of comorbidities1316
Psoriasis type  
    Vulgaris7683.8
    Inverse00
    Erythrodermic11.2
    Guttate00
    Pustular44.8
Time of onset of disease  
    Up to 18 years of age3138.6
    After 18 years of age5061.4
Lesion sites  
    Hand/foot2328.4
    Elbow/knee1214.8
    Back area44.9
    Abdominal area56.2
    Scalp2632.1
    Others1113.6
Total81100%

World Health Organization Classification, 2000;

International Diabetes Federation Classification, 2006.

Anthropometric measurements and clinical characteristics of psoriasis patients (n=81). João Pessoa (PB), Brazil, 2014 World Health Organization Classification, 2000; International Diabetes Federation Classification, 2006. Psoriasis type II more commonly occurs among family members, most often associated with an early onset of the disease.[1,2] In this sense, among the 6 patients under 18 years of age, half had a family member who was a psoriasis patient; and among the 75 patients of above 18 years of age, only 28 (37.3%) reported having a family member with psoriasis. As regards the clinical form of psoriasis, 76 patients (93.8%) presented psoriasis vulgaris, followed by 4 patients (4.9%) with pustular psoriasis (Table 2). Data from the literature indicate that psoriasis vulgaris was the most common disease, affecting approximately 80% to 90% of the patients.[1] Low prevalence of erythrodermal form of the disease in this study is justifiable, as it refers to outpatient services, whereas for specific cases of erythrodermic psoriasis, inpatient treatment would be required. Records showed that 53 people (65.4%) presented psoriatic arthritis. These high numbers are most likely due to the multidisciplinary nature of this Center, where Dermatology and Rheumatology work together, enabling more diagnoses. Lesions appear more frequently in portions of the body normally covered by clothes or protected by hair, that is, areas less exposed to ultraviolet radiation.[2,8] This study detected that in 26 patients (32.1%) lesions began mainly on the scalp, whereas in 23 patients (28.4%) they appeared first in the hands and feet. Literature shows that the presence of systemic diseases related to psoriasis is frequent.[1,3,8] The basis for these associations is complex: effects of chronic systemic inflammation, psychosocial problems, and potential adverse effects of treatment may be important.[1,3] The sample included 10 (12.3%) atopic patients (asthma, rhinitis, or atopic dermatitis carriers); 25 (30.9%) hypertensive patients; 18 (22.2%) diabetic patients, and 14 (17.3%) patients with dyslipidemias. Such results are compatible with studies that show that metabolic syndrome (MS), as a whole, and its isolated components have been associated with psoriasis (Table 2). [1,3,8] Therefore, the present study identified a psoriasis patient population consisting mostly of dark-skinned adult males with low education and income levels who were sedentary and obese, with increased abdominal circumferences; who were ex-smokers; and who did not consume alcohol. These patients were diagnosed with psoriasis vulgaris, which mainly began on the scalp, hands and feet. In addition, many had some type of associated comorbidity and relatives who had psoriasis. It is important to understand psoriasis patient profiles, considering the disease's high prevalence rate and the great impact on the patients' quality of life so that health promotion and intervention actions may be better targeted.
  5 in total

1.  Psoriasis: is the impairment to a patient's life cumulative?

Authors:  A B Kimball; U Gieler; D Linder; F Sampogna; R B Warren; M Augustin
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-05-07       Impact factor: 6.166

Review 2.  Psoriasis and obesity: literature review and recommendations for management.

Authors:  Gleison Vieira Duarte; Ivonise Follador; Carolina M Alves Cavalheiro; Thadeu S Silva; Maria de Fátima S P de Oliveira
Journal:  An Bras Dermatol       Date:  2010 May-Jun       Impact factor: 1.896

Review 3.  Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.

Authors:  Batya B Davidovici; Naveed Sattar; Jörg C Prinz; Prinz C Jörg; Luis Puig; Paul Emery; Jonathan N Barker; Peter van de Kerkhof; Mona Ståhle; Frank O Nestle; Giampiero Girolomoni; James G Krueger
Journal:  J Invest Dermatol       Date:  2010-05-06       Impact factor: 8.551

Review 4.  Smoking and psoriasis.

Authors:  Shahrad M Behnam; Shahdad E Behnam; John Y Koo
Journal:  Skinmed       Date:  2005 May-Jun

5.  Alcohol intake: a risk factor for psoriasis in young and middle aged men?

Authors:  K Poikolainen; T Reunala; J Karvonen; J Lauharanta; P Kärkkäinen
Journal:  BMJ       Date:  1990-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.